429 related articles for article (PubMed ID: 25471584)
1. Blocking lymphocyte trafficking with FTY720 prevents inflammation-sensitized hypoxic-ischemic brain injury in newborns.
Yang D; Sun YY; Bhaumik SK; Li Y; Baumann JM; Lin X; Zhang Y; Lin SH; Dunn RS; Liu CY; Shie FS; Lee YH; Wills-Karp M; Chougnet CA; Kallapur SG; Lewkowich IP; Lindquist DM; Murali-Krishna K; Kuan CY
J Neurosci; 2014 Dec; 34(49):16467-81. PubMed ID: 25471584
[TBL] [Abstract][Full Text] [Related]
2. Peripheral T Cell Depletion by FTY720 Exacerbates Hypoxic-Ischemic Brain Injury in Neonatal Mice.
Herz J; Köster C; Crasmöller M; Abberger H; Hansen W; Felderhoff-Müser U; Bendix I
Front Immunol; 2018; 9():1696. PubMed ID: 30127782
[TBL] [Abstract][Full Text] [Related]
3. TNFR1-JNK signaling is the shared pathway of neuroinflammation and neurovascular damage after LPS-sensitized hypoxic-ischemic injury in the immature brain.
Wang LW; Chang YC; Chen SJ; Tseng CH; Tu YF; Liao NS; Huang CC; Ho CJ
J Neuroinflammation; 2014 Dec; 11():215. PubMed ID: 25540015
[TBL] [Abstract][Full Text] [Related]
4. Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia.
Serdar M; Herz J; Kempe K; Lumpe K; Reinboth BS; Sizonenko SV; Hou X; Herrmann R; Hadamitzky M; Heumann R; Hansen W; Sifringer M; van de Looij Y; Felderhoff-Müser U; Bendix I
Brain Behav Immun; 2016 Feb; 52():106-119. PubMed ID: 26456693
[TBL] [Abstract][Full Text] [Related]
5. FTY720 ameliorates acute ischemic stroke in mice by reducing thrombo-inflammation but not by direct neuroprotection.
Kraft P; Göb E; Schuhmann MK; Göbel K; Deppermann C; Thielmann I; Herrmann AM; Lorenz K; Brede M; Stoll G; Meuth SG; Nieswandt B; Pfeilschifter W; Kleinschnitz C
Stroke; 2013 Nov; 44(11):3202-10. PubMed ID: 24029635
[TBL] [Abstract][Full Text] [Related]
6. Modulation of IL-33/ST2-TIR and TLR signalling pathway by fingolimod and analogues in immune cells.
Rüger K; Ottenlinger F; Schröder M; Zivković A; Stark H; Pfeilschifter JM; Radeke HH
Scand J Immunol; 2014 Dec; 80(6):398-407. PubMed ID: 25207757
[TBL] [Abstract][Full Text] [Related]
7. FTY720 reduces post-ischemic brain lymphocyte influx but does not improve outcome in permanent murine cerebral ischemia.
Liesz A; Sun L; Zhou W; Schwarting S; Mracsko E; Zorn M; Bauer H; Sommer C; Veltkamp R
PLoS One; 2011; 6(6):e21312. PubMed ID: 21701599
[TBL] [Abstract][Full Text] [Related]
8. [Fingolimod therapy in multiple sclerosis--the issue of the pathomechanism].
Tar L; Vécsei L
Ideggyogy Sz; 2012 Mar; 65(3-4):83-100. PubMed ID: 23136726
[TBL] [Abstract][Full Text] [Related]
9. Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720.
Fujiwara M; Anstadt EJ; Khanna KM; Clark RB
Clin Immunol; 2015 May; 158(1):103-13. PubMed ID: 25829233
[TBL] [Abstract][Full Text] [Related]
10. The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy.
Krämer S; Binder E; Loof T; Wang-Rosenke Y; Martini S; Khadzhynov D; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2009 Jul; 297(1):F218-27. PubMed ID: 19439518
[TBL] [Abstract][Full Text] [Related]
11. Monocytes promote acute neuroinflammation and become pathological microglia in neonatal hypoxic-ischemic brain injury.
Chen HR; Chen CW; Kuo YM; Chen B; Kuan IS; Huang H; Lee J; Anthony N; Kuan CY; Sun YY
Theranostics; 2022; 12(2):512-529. PubMed ID: 34976198
[No Abstract] [Full Text] [Related]
12. FTY720 reduces inflammation and promotes functional recovery after spinal cord injury.
Lee KD; Chow WN; Sato-Bigbee C; Graf MR; Graham RS; Colello RJ; Young HF; Mathern BE
J Neurotrauma; 2009 Dec; 26(12):2335-44. PubMed ID: 19624262
[TBL] [Abstract][Full Text] [Related]
13. Development of cerebral gray and white matter injury and cerebral inflammation over time after inflammatory perinatal asphyxia.
Bonestroo HJ; Heijnen CJ; Groenendaal F; van Bel F; Nijboer CH
Dev Neurosci; 2015; 37(1):78-94. PubMed ID: 25634435
[TBL] [Abstract][Full Text] [Related]
14. Cytoprotective Actions of FTY720 Modulate Severe Preservation Reperfusion Injury in Rat Renal Transplants.
Fuller TF; Hoff U; Kong L; Naether M; Wagner P; Nieminen-Kelhä M; Nolting J; Luft FC; Hegner B; Dragun D
Transplantation; 2010 Feb; 89(4):402-8. PubMed ID: 20177341
[TBL] [Abstract][Full Text] [Related]
15. Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis.
Mehling M; Lindberg R; Raulf F; Kuhle J; Hess C; Kappos L; Brinkmann V
Neurology; 2010 Aug; 75(5):403-10. PubMed ID: 20592255
[TBL] [Abstract][Full Text] [Related]
16. Intranasal delivery of cell-penetrating anti-NF-κB peptides (Tat-NBD) alleviates infection-sensitized hypoxic-ischemic brain injury.
Yang D; Sun YY; Lin X; Baumann JM; Dunn RS; Lindquist DM; Kuan CY
Exp Neurol; 2013 Sep; 247():447-455. PubMed ID: 23353638
[TBL] [Abstract][Full Text] [Related]
17. FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury.
Dragun D; Böhler T; Nieminen-Kelhä M; Waiser J; Schneider W; Haller H; Luft FC; Budde K; Neumayer HH
Kidney Int; 2004 Mar; 65(3):1076-83. PubMed ID: 14871428
[TBL] [Abstract][Full Text] [Related]
18. Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R⁻/⁻) mice.
Poti F; Costa S; Bergonzini V; Galletti M; Pignatti E; Weber C; Simoni M; Nofer JR
Vascul Pharmacol; 2012 Aug; 57(1):56-64. PubMed ID: 22459073
[TBL] [Abstract][Full Text] [Related]
19. A novel immunosuppressant, FTY720, induces peripheral lymphodepletion of both T- and B cells and immunosuppression in baboons.
Quesniaux V; Fullard L; Arendse H; Davison G; Markgraaff N; Auer R; Ehrhart F; Kraus G; Schuurman HJ
Transpl Immunol; 1999 Sep; 7(3):149-57. PubMed ID: 10608298
[TBL] [Abstract][Full Text] [Related]
20. FTY720 improves functional recovery after spinal cord injury by primarily nonimmunomodulatory mechanisms.
Norimatsu Y; Ohmori T; Kimura A; Madoiwa S; Mimuro J; Seichi A; Yatomi Y; Hoshino Y; Sakata Y
Am J Pathol; 2012 Apr; 180(4):1625-35. PubMed ID: 22417787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
